Press Releases
Marimekko Corporation, Press release, 6 May 2024 at 9.30 a.m.
Marimekko celebrates the 60th anniversary of the Unikko print in Helsinki and Tokyo with public open-air fashion shows
The annual Marimekko Day is celebrated in mid-May with a public open-air fashion show in Helsinki and in Marimekko stores globally. To celebrate the 60-year-old iconic Unikko print, the fashion show will also be seen in Tokyo for the first time.
Esplanade Park in the... (continue reading...)
2024 FINANCIAL CALENDAR - Update
Paris, 6 May 2024
Q1 2024 sales: 27 May 2024*
- Quiet period: from 13 May to 27 May 2024
Annual General Meeting: 14 June 2024
New date – Capital Markets Day: 19 June 2024
Update – Half-year results and Q2 2024 sales: 23 September 2024*
- Update – Quiet period: from 9 to 23 September 2024
Q3 2024 sales: 27 November 2024*
- Quiet period: from 13 to 27 November 2024
* Publication after the closing of the Premier Marché of... (continue reading...)
STOCKHOLM, May 6, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced data from the proof-of-concept Phase 2 trial evaluating setanaxib, its lead NOX enzyme inhibitor, in combination with pembrolizumab, in patients with squamous cell carcinoma of the head and neck (SCCHN). The analysis showed statistically significant improvements in progression-free survival (PFS), as well as in overall survival... (continue reading...)
Amsterdam, 6 May 2024
EXOR N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM
Exor N.V. (AMS: EXO) (“Exor” or the “Company”) announces that, under the first tranche of the share buyback program of up to €125 million announced on 15 April 2024 (the “first tranche”), the Company has completed the following transactions on Euronext Amsterdam and CBOE DXE:
EURONEXT AMSTERDAM
Trading DateNumber of ordinary shares purchasedAverage price per share excluding fees... (continue reading...)Vancouver, British Columbia--(Newsfile Corp. - May 6, 2024) - Graphano Energy Ltd. (TSXV: GEL) (OTCQB: GELEF) (FSE: 97G0) ("Graphano" or the "Company") is pleased to report final assay results from the 2023-24 winter drilling program at its 100% owned Lac Aux Bouleaux ("LAB") Graphite Property situated adjacent to Canada's only producing graphite mine in Qu�bec, Canada, the Lac des Iles Mine. The primary focus of the drilling program was graphite zone expansion,... (continue reading...)
More Press Releases
View Older Stories-
KKR to Acquire Healthium from Apax Funds
-
TerraPay Continues to Attract Top Industry Talent, Names Hassan Chatila as Vice President and Global Head of Network
-
BrainChip and Frontgrade Gaisler to Augment Space-Grade Microprocessors with AI Capabilities
-
Xylem Unveils 'Reuse Brew'
-
SES to acquire Intelsat: Investor Relations Frequently Asked Questions
-
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
-
Health Canada Approves Nexstim NBS 6 System for Treatment of MDD
-
Aktsiaselts Infortar interim report for Q1 2024
-
Fingerprints and Infrafon collaborating on new smart badges for the European Medical and IoT market
-
Subsea7 share repurchases
-
M&P Receives a Specific License From the OFAC in Relation to Its Operations in Venezuela
-
Statement Concerning Eutelsat Group’s Ground Network
-
Ambri Agrees to Terms of Proposed Sale with Lender Consortium
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
-
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
-
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
-
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
-
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
-
Transaction in Own Shares
-
Declaration of shares and voting rights April 30, 2024 - VALNEVA SE
-
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
-
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
-
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
-
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
-
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
-
Start of Day Message
-
Market Update
-
Sohu.com to Report First Quarter 2024 Financial Results on May 20, 2024
-
CARMAT Continues to Build on Its Momentum in the EFICAS Study and Reiterates Confidence in Its 2024 Outlook
-
Elliptic Labs Shipping on vivo V30e Smartphone
-
Subc – Ex. Dividend Nok 3.00 Today
-
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Region
-
Dividend Payments Ex-date of AS Tallinna Sadam
-
Invitation to DNO Q1 2024 Earnings Call
-
Revised agenda of the Ordinary General Meeting of 21 May 2024
-
TGS Secures New Ocean Bottom Node Data Acquisition Contract in North America
-
Corbion reports the progress of its € 20 million share buyback program 29 April – 3 May 2024
-
Global Times: Xi starts state visit to France, commends bilateral relations
-
IRLAB: Invitation to the Interim Report for Q1 2024 Presentation and Webcast
-
IZE Fintech Blockchain (IZE) Is Now Available for Trading on LBank Exchange
-
McAfee and Intel Showcase AI-Powered Deepfake Detection Technology on the AI PC at RSA
-
Napleton Auto Group Ranked Highest in 2024 Auto Industry Study Measuring Response to Website Customers
-
The Bradford Exchange Mint Celebrates the Royal Succession
-
Asset Managers Need to Set a Strategy to Leverage the AI Opportunity and Drive Future Growth
-
Novo Nordisk Foundation, Wellcome, and the Gates Foundation Join Forces to Accelerate Global Health Equity and Impact
-
Lucky Monkey Coffee Aims to Innovate Vietnamese Coffee to Save Calories and Time
-
"Float Your Boat" Itinerary Unfurls A Maritime Adventure Across Pierce County
-
Taste of Tribeca Celebrates 30th Anniversary: A Culinary Extravaganza and Public School Arts Fundraiser